We fight for human health.

CureVac is the first company to successfully harness messenger RNA (mRNA) for medical purposes. The principle is promising; use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases.

  • CureVac Appoints Pierre Kemula as Chief Financial Officer

    Press Release of October 11, 2016

    Read more
  • Study in Peer-Reviewed Journal Vaccine Demonstrates Decoding Mode of Action of mRNA Vaccines

    Press Release of July 14, 2016

    Read more
  • Study publication in PLOS Neglected Tropical Disease

    "An mRNA Vaccine Encoding Rabies Virus Glycoprotein Induces Protection ..."

    Read more
  • Media Report in The Wall Street Journal on May 23, 2016

    Ebola, Zika Push Global Health Leaders on Disease Fight... (Photo: Felipe Dana/AP)

    Read more
  • CureVac raises $110 Million in a private placement

    Further investment for development of mRNA products

    Read more
  • Work@CureVac

    Do you want to fight together with us for human health? You will find current vacancies on our CareerPortal.

    Read more